No effect of montelukast on asthma-like symptoms in elite ice hockey players




Helenius I, Lumme A, Ounap J, Obase Y, Rytila P, Sarna S, Alaranta A, Remes V, Haahtela T

PublisherBLACKWELL MUNKSGAARD

2004

Allergy

ALLERGY

ALLERGY

59

1

39

44

6

0105-4538

DOIhttps://doi.org/10.1046/j.1398-9995.2003.00353.x



Conclusion: A leukotriene antagonist, montelukast, was of no benefit in the treatment of asthma-like symptoms, increased bronchial hyperresponsiveness or a mixed type of eosinophilic and neutrophilic airway inflammation in highly-trained ice hockey players.




Last updated on 2025-14-10 at 09:44